CIK 0000872912 · Non-accelerated filer<br>Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061245881
- Phone
- (518) 743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $488,508
- in 1 filing
Net −$488,508. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | Pennell Sandra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +56,500 | 56,500 | ||
| 2026-02-17 | Pennell Sandra Chief Financial Officer | Grant or award · Restricted Stock Units | +28,250 | 28,250 | ||
| 2026-02-17 | Vukovic Vojo CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +56,500 | 56,500 | ||
| 2026-02-17 | Vukovic Vojo CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +28,250 | 28,250 | ||
| 2026-02-17 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2026-02-17 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +97,500 | 97,500 | ||
| 2025-11-21 | Sylvester John Richard Director | Purchase | +4,386 | $8.89 | $39K | 14,936 |
| 2025-11-11 | MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Purchase | +11,500 | $8.53 | $98K | 330,834 |
| 2025-06-12 | Vukovic Vojo CHIEF MEDICAL OFFICER | Option exercise | +42,000 | $4.78 | $201K | 168,882 |
| 2025-06-12 | Vukovic Vojo CHIEF MEDICAL OFFICER | Option exercise · Employee Stock Option (Right to Buy) | −42,000 | 58,500 | ||
| 2025-05-15 | Sylvester John Richard Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2025-05-15 | SALAMON STEVEN A J Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2025-05-15 | CZEREPAK ELIZABETH Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2025-05-15 | Aharon Gil Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2025-05-15 | Martell Bridget A Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2025-05-05 | Aharon Gil Director | Option exercise | +400,000 | $10.00 | $4.0M | 3,413,468 |
| 2025-05-05 | SALAMON STEVEN A J Director | Option exercise | +400,000 | $10.00 | $4.0M | 3,413,468 |
| 2025-05-05 | Rosalind Advisors, Inc. Director | Option exercise | +400,000 | $10.00 | $4.0M | 3,413,468 |
| 2025-02-07 | Hoffman David L. GEN'L COUNSEL, CCO & SECY | Grant or award · Stock Option (Right to Buy) | +113,000 | 113,000 | ||
| 2025-02-07 | Pennell Sandra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +113,000 | 113,000 |
Page 2 of 7 · 138 trades